1. Home
  2. ICCC vs CPSH Comparison

ICCC vs CPSH Comparison

Compare ICCC & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$11.11

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Logo CPS Technologies Corp.

CPSH

CPS Technologies Corp.

HOLD

Current Price

$4.38

Market Cap

90.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
CPSH
Founded
1982
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
93.1M
90.8M
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
ICCC
CPSH
Price
$11.11
$4.38
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
23.8K
318.5K
Earning Date
05-15-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
113.64
EPS
0.21
N/A
Revenue
$26,493,169.00
N/A
Revenue This Year
N/A
$16.41
Revenue Next Year
N/A
$20.16
P/E Ratio
$51.19
N/A
Revenue Growth
51.64
N/A
52 Week Low
$4.52
$2.70
52 Week High
$12.10
$14.39

Technical Indicators

Market Signals
Indicator
ICCC
CPSH
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
ICCC
CPSH

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

About CPSH CPS Technologies Corp.

CPS Technologies Corp designs, manufactures, and sells high-performance material solutions for customers across various markets, including transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company develops and applies proprietary expertise in metal matrix composites (MMCs), which are engineered materials combining metals and ceramics to achieve enhanced performance properties. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers. The majority of the company's revenue is derived from the sale of its products in the United States of America.

Share on Social Networks: